
Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study
Author(s) -
Matthew R. Smith,
Christopher J. Sweeney,
Paul G. Corn,
Dana E. Rathkopf,
David Smith,
Maha Hussain,
Daniel J. George,
Celestia S. Higano,
Andrea L. Harzstark,
A. Oliver Sartor,
Nicholas J. Vogelzang,
Michael S. Gordon,
Johann S. de Bono,
Naomi B. Haas,
Christopher J. Logothetis,
Aymen Elfiky,
Christian Scheffold,
A. Douglas Laird,
Frauke Schimmöller,
Ethan Basch,
Howard I. Scher
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/yxdm-6w50
Subject(s) - cabozantinib , medicine , prostate cancer , chemotherapy , oncology , cancer , prostate , castration , hormone